Biomaterial Database

Neural transplantation: problems and prospects for therapeutic application. 1992

J D Sinden, and S N Patel, and H Hodges

Department of Psychology, Institute of Psychiatry, London, UK.

Successful demonstrations of behavioural recovery in a variety of lesion and mutant animal models have encouraged the application of neural transplantation to the alleviation of neurodegenerative disease. Apart from the continuing shortage of foetal tissue, the major problems to be resolved for successful application of neural transplantation to humans are: first, immune rejection of allograft tissue and its pathological consequences to both graft and host tissue; and second, the establishment of normal and extensive graft-host connectivity. Recent developments in transplant research are beginning successfully to apply a number of strategies to resolve these problems.

UI	MeSH Term	Description	Entries
D009416	Nerve Regeneration	Renewal or physiological repair of damaged nerve tissue.	Nerve Tissue Regeneration,Nervous Tissue Regeneration,Neural Tissue Regeneration,Nerve Tissue Regenerations,Nervous Tissue Regenerations,Neural Tissue Regenerations,Regeneration, Nerve,Regeneration, Nerve Tissue,Regeneration, Nervous Tissue,Regeneration, Neural Tissue,Tissue Regeneration, Nerve,Tissue Regeneration, Nervous,Tissue Regeneration, Neural
D010300	Parkinson Disease	A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)	Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D001921	Brain	The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.	Encephalon
D006084	Graft Rejection	An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.	Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006650	Histocompatibility Testing	Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed)	Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818	Animals	Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.	Animal,Metazoa,Animalia
D016332	Fetal Tissue Transplantation	Transference of fetal tissue between individuals of the same species or between individuals of different species.	Grafting, Fetal Tissue,Transplantation, Fetal Tissue,Fetal Tissue Donation,Donation, Fetal Tissue,Donations, Fetal Tissue,Fetal Tissue Donations,Fetal Tissue Grafting,Fetal Tissue Graftings,Fetal Tissue Transplantations,Graftings, Fetal Tissue,Tissue Donation, Fetal,Tissue Donations, Fetal,Tissue Grafting, Fetal,Tissue Graftings, Fetal,Tissue Transplantation, Fetal,Tissue Transplantations, Fetal,Transplantations, Fetal Tissue
D016380	Brain Tissue Transplantation	Transference of brain tissue, either from a fetus or from a born individual, between individuals of the same species or between individuals of different species.	Grafting, Brain Tissue,Transplantation, Brain Tissue,Brain Tissue Grafting,Brain Tissue Graftings,Brain Tissue Transplantations,Graftings, Brain Tissue,Tissue Grafting, Brain,Tissue Graftings, Brain,Tissue Transplantation, Brain,Tissue Transplantations, Brain,Transplantations, Brain Tissue
D018377	Neurotransmitter Agents	Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.	Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve